Assignee
VETTORE LLC
US·7 granted patents·5 pending applications·24 citations·filing 2016–2025
Top patents by PatentIndex Score
12 records- 0195US11155522B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2020·Granted Oct 26, 2021·4 cites·41 claims
- 0293US12187682B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2023·Granted Jan 7, 2025·1 cites·9 claims
- 0393US11724989B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2021·Granted Aug 15, 2023·2 cites·23 claims
- 0493US10214492B2Heterocyclic inhibitors of MCT4VETTORE LLC·Filed 2017·Granted Feb 26, 2019·6 cites·5 claims
- 0592US11292767B2Heterocyclic inhibitors of MCT4VETTORE LLC·Filed 2018·Granted Apr 5, 2022·5 cites·31 claims
- 0692US10202350B2MCT4 inhibitors for treating diseaseVETTORE LLC·Filed 2016·Granted Feb 12, 2019·6 cites·39 claims
- 0790US2026055062A1Heterocyclic inhibitors of mct4VETTORE LLC·Filed 2025·Application pending·0 cites
- 0887US2025257039A1Mct4 inhibitors for treating diseaseVETTORE LLC·Filed 2024·Application pending·0 cites
- 0977US12492171B2Heterocyclic inhibitors of MCT4VETTORE LLC·Filed 2022·Granted Dec 9, 2025·0 cites·9 claims
- 1072US2019112274A1Mct4 inhibitors for treating diseaseVETTORE LLC·Filed 2018·Application pending·0 cites
- 1140US2025179049A1Salts of heterocyclic inhibitors of monocarboxylate transporter 4 for the treatment of diseaseVETTORE LLC·Filed 2025·Application pending·0 cites
- 1234US2025206723A1Methods and processes for the preparation of mct4 inhibitorsVETTORE LLC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →